Crescent Biopharma, Inc. (CBIO)

Last Closing Price: 20.74 (2026-05-22)

Expense Ratio (Quarterly)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Crescent Biopharma, Inc. (CBIO) Expense Ratio data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$1.04M
$-23.28M
--
$1.04M
$25.77M
$-24.73M
$1.45M
$-23.28M
$-23.28M
$-23.28M
$-23.28M
$-23.28M
$-23.28M
$-24.73M
$-24.66M
30.40M
30.40M
$-0.70
$-0.70
Balance Sheet Financials
$195.56M
$0.93M
$3.57M
$199.13M
$14.19M
--
$1.09M
$15.28M
$179.85M
$183.85M
$183.85M
27.57M
Cash Flow Statement Financials
$-8.94M
$-8.15M
$-6.95M
$213.30M
$189.27M
$-24.03M
$4.11M
--
--
Fundamental Metrics & Ratios
13.78
--
--
--
--
100.00%
-2380.08%
-2380.08%
--
-2240.91%
-2240.91%
$-9.08M
--
Expense Ratio
--
--
0.01
--
--
--
-12.95%
-12.66%
-11.69%
-12.66%
$6.67
$-0.30
$-0.29